Meet Biogen’s leadership team
Daniel Karp is Executive Vice President, Corporate Development at Biogen and has served on the Executive Committee since June 2018. He leads the Corporate Development function, which includes corporate and business development and corporate strategy.
Prior to joining Biogen, he spent more than a decade at Pfizer where he most recently served as Vice President, Worldwide Business Development and Head of Business Development for Worldwide Research & Development. He also held corporate and business development roles spanning rare diseases, gene therapy, vaccines, oncology and specialty care, with experience including mergers and acquisitions, licensing and scientific collaborations.
Earlier in his career, Mr. Karp served as a consultant focused on healthcare and life sciences strategy.
He holds a B.S. in biology from Duke University and an MBA from the Wharton School of the University of Pennsylvania.